Isabel Paxton has a strong background in clinical research and study startup processes, currently serving as a Study Start Up Associate II at ICON plc from August 2024 to September 2025. Prior experience includes working as a Regulatory Scientist and as a Site Activation Specialist II at Syneos Health from September 2023 to August 2024. Isabel's prior roles at PPD from June 2019 to July 2021 encompassed a variety of positions, including Clinical Trial Coordinator, Site Activation Coordinator, Country Approval Associate, and Remote Site Monitor. Isabel holds both a Master of Science and a Bachelor of Science from the University of Reading, earned between 2014 and 2018.
This person is not in the org chart
This person is not in any teams
This person is not in any offices